Daniel Sarpong, PhD

Dr. Daniel F. Sarpong is a Senior Research Scientist and Executive Director of the Office of Health Equity Research at the Yale School of Medicine, where he translates complex biological and social determinants into strategic frameworks for population health. A doctoral-trained biostatistician from Louisiana State University Medical Center, he has a career marked by the architectural design of high-impact research infrastructures that bridges advanced data science and community-driven outcomes.

As a premier strategic collaborator, Dr. Sarpong currently serves as the Multiple Principal Investigator (MPI) for the national RCMI Coordinating Center, synchronizing intellectual exchange and research capacity across a network of 23 NIH-funded institutions. His stewardship of high-stakes research includes managing $50 million in federal funding as Director and Co-PI of the Jackson Heart Study, the global benchmark for longitudinal cardiovascular research in African Americans. He has also led Community Engagement Cores for major initiatives such as the Louisiana Clinical and Translational Science (LA CaTS) Center, fostering cohesive enterprises for translational science.

Dr. Sarpong is a prolific educator and dedicated mentor, having held tenured professorships at Xavier University of Louisiana and Jackson State University. He has served as a primary advisor or committee member for dozens of PhD and DrPH candidates and continues to shape the future biomedical workforce as a faculty mentor for nationally funded programs, including the Yale-DAHRS addiction research program and the University of Miami PRIDE Program. His teaching portfolio spans advanced biostatistics, program evaluation, and clinical trial methodology, reflecting three decades of academic leadership.

Beyond academia, he is a sought-after international consultant specializing in Pharmacoeconomics and program evaluation. He has led technical consultancies for Jamaica's National Council on Drug Abuse and serves as an invited faculty member for the Caribbean Association of Pharmacists, delivering specialized training in more than 10 countries. His consultancy includes rigorous impact assessments for the CDC and the Satcher Health Leadership Institute, translating complex biomedical data into actionable public health policy.